Literature DB >> 3526180

Intrathecal administration of natural human interferon alpha in amyotrophic lateral sclerosis.

J S Mora, T L Munsat, K P Kao, L J Finison, W Hedlund, G A Bradley, R Scheife, J A Georgiades.   

Abstract

Ten patients with amyotrophic lateral sclerosis were given intrathecal injections of natural interferon alpha, 1 million units weekly for 7 to 24 weeks. Six patients completed the trial. Four voluntarily withdrew after 7 to 13 injections. The slopes of deterioration for 40 quantitative tests of neuromuscular function for the control and treatment periods were compared by paired t test in the six patients who completed the trial and in the patient who withdrew after 13 injections. No significant differences were found. The patients tolerated treatment well. The CSF reaction was modest and spontaneously reversible. Indomethacin and ibuprofen blocked interferon side effects.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3526180     DOI: 10.1212/wnl.36.8.1137

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Interferon- alpha and - beta restrict polyomavirus JC replication in primary human fetal glial cells: implications for progressive multifocal leukoencephalopathy therapy.

Authors:  Juliene K G Co; Saguna Verma; Ulziijargal Gurjav; Laarni Sumibcay; Vivek R Nerurkar
Journal:  J Infect Dis       Date:  2007-07-20       Impact factor: 5.226

2.  T4, T3 and rT3 levels in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.

Authors:  J P Malin; R Ködding; H Fuhrmann; A von zur Mühlen
Journal:  J Neurol       Date:  1989-01       Impact factor: 4.849

3.  Inflammatory profiles relate to survival in subtypes of amyotrophic lateral sclerosis.

Authors:  Mads Nikolaj Olesen; Anna Wuolikainen; Anna Christine Nilsson; Martin Wirenfeldt; Karin Forsberg; Jonna Skov Madsen; Soeren Thue Lillevang; Ivan Brandslund; Peter Munch Andersen; Nasrin Asgari
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-03-02

4.  Multicentre double-blind study of effect of intrathecally administered natural human fibroblast interferon on exacerbations of multiple sclerosis.

Authors:  L Jacobs; A M Salazar; R Herndon; P A Reese; A Freeman; R Josefowicz; A Cuetter; F Husain; W A Smith; R Ekes
Journal:  Lancet       Date:  1986 Dec 20-27       Impact factor: 79.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.